Phesgo 50242-0245-01
Generic: Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 29, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA761170
Need to source Phesgo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hyaluronidase (human Recombinant) | 30000 U/15mL |
| Pertuzumab | 1200 mg/15mL |
| Trastuzumab | 600 mg/15mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]Endoglycosidase [EPC]Endoglycosidase [EPC]
Selected Package
50242-0245-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE